Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zura Bio LtdZURA · Entity 5413 | See Remarks | April 01, 2026 | April 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zura Bio Ltd
Report date April 01, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.03 · Expires 2036-04-01 | Direct | 340,900 |
Reported balance
After 2026-04-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 340,900 · Balance 340,900 F1: One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 2, 2026 18:00 UTC | Zura Bio Ltd ZURA · Entity 5413 | GrantEmployee Share Option (Right to Buy) · Derivative | 340,900 | $0.00 Strike: $6.03 | $0.00 |
DisclosureSEC source: 0002003539-26-000002 · form4-04022026_060418.xml · derivative · entry 1 Nistala Kiran · CIK 0002003539 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,900 Underlying: Class A Ordinary Shares · 340,900 shares Expires 2036-04-01 F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 17:02 UTC | Zura Bio Ltd ZURA · Entity 5413 | GrantEmployee Share Option (Right to Buy) · Derivative | 341,700 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001415889-25-006203 · form4-03032025_100351.xml · derivative · entry 1 Nistala Kiran · CIK 0002003539 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,700 Underlying: Class A Ordinary Shares · 341,700 shares Expires 2035-02-27 F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 18:10 UTC | Zura Bio Ltd ZURA · Entity 5413 | GrantEmployee Share Option (Right to Buy) · Derivative | 285,000 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0001415889-24-017860 · form4-06212024_060603.xml · derivative · entry 1 Nistala Kiran · CIK 0002003539 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,000 Underlying: Class A Ordinary Shares · 285,000 shares Expires 2034-06-18 F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| April 22, 2024 Filed Apr 24, 2024 18:53 UTC | Zura Bio Ltd ZURA · Entity 5413 | PurchaseClass A ordinary shares | 3,195 | $3.13 | $10,000.35 |
DisclosureSEC source: 0001415889-24-011481 · form4-04242024_100419.xml · nonDerivative · entry 1 Nistala Kiran · CIK 0002003539 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,195 F1 · kind: These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and the Reporting Person at a purchase price of $3.13 per share. Read SEC document |
| April 22, 2024 Filed Sep 9, 2024 16:10 UTC Amendment | Zura Bio Ltd ZURA · Entity 5413 | GrantClass A ordinary shares | 3,195 | $3.13 | $10,000.35 |
DisclosureSEC source: 0001415889-24-023064 · form4a-09092024_040901.xml · nonDerivative · entry 1 Nistala Kiran · CIK 0002003539 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,195 F1 · kind: On April 24, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'A' instead of transaction code 'P'. F2 · shares: These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and the Reporting Person at a purchase price of $3.13 per share. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 11:27 UTC | Zura Bio Ltd ZURA · Entity 5413 | GrantStock options · Derivative | 350,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001104659-24-007062 · tm244212-1_4seq1.xml · derivative · entry 1 Nistala Kiran · CIK 0002003539 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Class A Ordinary Shares · 350,000 shares Expires 2034-01-24 F1 · shares: Consists of options to purchase 350,000 Class A Ordinary Shares. The vesting for 350,000 shares began on November 27, 2023 and would vest over a period of four years, with 1/4 to be vested on 11/27/2024, and thereafter 1/48 on a monthly basis. F1 · derivative.exercise_date: Consists of options to purchase 350,000 Class A Ordinary Shares. The vesting for 350,000 shares began on November 27, 2023 and would vest over a period of four years, with 1/4 to be vested on 11/27/2024, and thereafter 1/48 on a monthly basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.